Register Login

Kura Oncology Inc (KURA)

(90% Positive) Kura Oncology Inc (KURA) Announces Enrollment Update for approved Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 8:59 p.m.

    📋 Kura Oncology Inc (KURA) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 06:05:14

    Event Type: Clinical Trial Update

    Event Details:

    Kura Oncology Inc (KURA) Announces Clinical Trial Update Kura Oncology Inc (KURA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: approved, medicines
    • Collaboration: NPM1
    • Updated Timeline: November 13, 2025, December 31, 2025

    🔬 Clinical Development Pipeline (Kura Oncology Inc):

    Product Type Development Stage Therapeutic Area Source
    Adagrasib DRUG Phase PHASE1 Solid Tumors With HRAS Alterations ClinicalTrials.gov
    Quizartinib DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Tipifarnib DRUG Phase PHASE1 HNSCC ClinicalTrials.gov
    Gilteritinib DRUG Phase PHASE1 AML ClinicalTrials.gov
    Venetoclax DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Cytarabine (Ara-C) DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Daunorubicin DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Azacitidine (AZA) DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Ziftomenib DRUG Phase PHASE3 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Azacitidine DRUG Phase PHASE1 Refractory Acute Leukemia ClinicalTrials.gov
    Mezigdomide DRUG Phase PHASE1 KMT2A-rearranged ClinicalTrials.gov
    n-dodecyl-B-D-maltoside OTHER Phase PHASE3 Non Muscle Invasive Bladder Cancer ClinicalTrials.gov
    Cretostimogene Grenadenorepvec DRUG Phase PHASE3 Non Muscle Invasive Bladder Cancer ClinicalTrials.gov
    Cabozantinib DRUG Phase PHASE1 Solid Tumors With HRAS Alterations ClinicalTrials.gov
    Darlifarnib DRUG Phase PHASE1 Solid Tumors With HRAS Alterations ClinicalTrials.gov
    imatinib mesylate DRUG Phase PHASE1 Gastrointestinal Stromal Tumor (GIST) ClinicalTrials.gov
    Alpelisib DRUG Phase PHASE1 HNSCC ClinicalTrials.gov
    Gemtuzumab DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Granulocyte colony-stimulating factor BIOLOGICAL Phase PHASE1 AML ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE1 AML ClinicalTrials.gov
    Idarubicin DRUG Phase PHASE1 AML ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE1 AML ClinicalTrials.gov
    Itraconazole DRUG Phase PHASE1 Advanced Malignant Neoplasm ClinicalTrials.gov
    Midazolam DRUG Phase PHASE1 Advanced Malignant Neoplasm ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Multigated Acquisition Scan PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Leukapheresis PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Hydroxyurea DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Echocardiography Test PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Bone Marrow Biopsy PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Bone Marrow Aspiration PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    KO-947 DRUG Phase PHASE1 Advanced Malignant Neoplasm ClinicalTrials.gov
    tarloxotinib bromide DRUG Phase PHASE2 NSCLC, Stage IV ClinicalTrials.gov
    TH-4000 (Tarloxotinib) DRUG Phase PHASE2 Non-small Cell Lung Cancer ClinicalTrials.gov
    Osimertinib DRUG Phase PHASE1 NSCLC ClinicalTrials.gov
    Milademetan DRUG Phase PHASE1 Cardiac Repolarization ClinicalTrials.gov
    Moxifloxacin (positive control) DRUG Phase PHASE1 Cardiac Repolarization ClinicalTrials.gov
    Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL) BEHAVIORAL Phase PHASE2 Advanced or Metastatic Breast Cancer ClinicalTrials.gov
    HRAS Detection Assay DEVICE Phase PHASE2 HRAS Gene Mutation ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Sotorasib and Tarloxotinib DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    RAIN-32 DRUG Phase PHASE2 Solid Tumors ClinicalTrials.gov
    KO-2806 DRUG Phase PHASE1 Solid Tumors With HRAS Alterations ClinicalTrials.gov
    Trabectedin DRUG Phase PHASE3 Dedifferentiated Liposarcoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Kura Oncology Inc
    • Ticker Symbol: KURA

Search

News categories